Publications by authors named "Mark P Marriott"

Claim this Profile
R
Response to treatment in NMOSD: the Australasian experience.
Laura Clarke, Wajih Bukhari, Cullen M O'Gorman, Elham Khalilidehkordi, Simon Arnett, Mark P Marriott

Mult Scler Relat Disord· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis.
Laura Clarke, Simon Arnett, Wajih Bukhari, Elham Khalilidehkordi, Sofia Jimenez Sanchez, Mark P Marriott

Front Neurol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study.
Nabil Seery, Sifat Sharmin, Vivien Li, Ai-Lan Nguyen, Claire Meaton, Mark P Marriott

CNS Drugs· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia.
Nabil Seery, Vivien Li, Ai-Lan Nguyen, Izanne Roos, Katherine A Buzzard, Mark P Marriott

Mult Scler Relat Disord· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation.
Elham Khalilidehkordi, Laura Clarke, Simon Arnett, Wajih Bukhari, Sofia Jimenez Sanchez, Mark P Marriott

Front Neurol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical profile of NMOSD in Australia and New Zealand.
Wajih Bukhari, Laura Clarke, Cullen O'Gorman, Elham Khalilidehkordi, Simon Arnett, Mark P Marriott

J Neurol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and prevalence of NMOSD in Australia and New Zealand.
Wajih Bukhari, Kerri M Prain, Patrick Waters, Mark Woodhall, Cullen M O'Gorman, Mark P Marriott

J Neurol Neurosurg Psychiatry· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remote Sensing of Vital Signs: A Wearable, Wireless "Band-Aid" Sensor With Personalized Analytics for Improved Ebola Patient Care and Worker Safety.
Steven R Steinhubl, Mark P Marriott, Stephan W Wegerich

Glob Health Sci Pract· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galanin is an autocrine myelin and oligodendrocyte trophic signal induced by leukemia inhibitory factor.
Melissa M Gresle, Helmut Butzkueven, Victoria M Perreau, Anna Jonas, Junhua Xiao, Mark P Marriott

Glia· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair.
Mark P Marriott, Ben Emery, Holly S Cate, Michele D Binder, Dennis Kemper

Glia· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
Helmut Butzkueven, Ben Emery, Tania Cipriani, Mark P Marriott, Trevor J Kilpatrick

Glia· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis